m+Medelevator.RU
← Поиск публикаций
ACS sensors · 2025

Dual-Color Visualization of Hepatic Fibrosis and Multidimensional Assessment of Therapeutic Drugs by a Multifunctional Single-Molecular Fluorescent Probe.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ou Jiale, Fang Min, Chen Man, Wang Chengyuan, Xu Xianyun, Wang Qi, Feng Yan, Meng Xiangming

Аннотация

There is a high relevance between changes in ClO- levels/mitochondrial morphology and the development of hepatic fibrosis; however, the efficient tools that are capable of real-time monitoring both of them and exploring their interrelations are extremely rare. Herein, we developed a multifunctional fluorescent probe based on a "three-in-one" strategy, named Mito-XS, which is firmly anchored in mitochondria, allowing for the ratiometric detection of ClO- and the accurate analysis of mitochondrial morphology. Probe Mito-XS can sensitively capture the changes of ClO- levels in mitochondria and successfully achieve simultaneous real-time monitoring of ClO- levels and mitochondrial morphology during oxidative stress. Utilizing probe Mito-XS, the evaluations of three therapeutic drugs (silymarin, methyl ferulic acid, and puerarin) on protecting cells from CCl4-induced damage were visualized by assessing their capabilities of inhibiting ClO- levels and maintaining mitochondrial morphology. Furthermore, dual-color imaging in hepatic fibrosis mice models revealed the exacerbation of hepatic fibrosis, and the therapeutic effect of puerarin can be tracked by the fluctuation of ClO- levels. Therefore, probe Mito-XS is an effective imaging tool to monitor mitochondrial morphology and ClO- levels at the same time and has the potential to work as an evaluation tool to screen therapeutic drugs for hepatic fibrosis treatment.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты